SCHERING-PLOUGH LABO, N.V. ,   Belgium

Glucocorticosteroid for topical application
Pinhalation powder dosed, 200 mcg / dose and 400 μg / dose.
glucocorticosteroid for topical use + keratolytic agent

Ointment for external use, 0.05% + 3%.

glucocorticosteroid for topical use + keratolytic agent

Solution for external use, 0.05% + 2%.

glucocorticosteroid

Suspension for injection, 2 mg + 5 mg / ml.

Cytokine

Solution for intravenous and subcutaneous administration, 18 million IU, 25 million IU, 30 million IU and 60 million IU.

antitumor agent - antibodies monoclonal
Concentrate for the preparation of a solution for infusions, 25 mg / ml.
Antiallergic - H1 histamine receptor blocker
Syrup 1 mg / ml.
Antiallergic - H1 histamine receptor blocker
Tablets 10 mg.
Glucocorticosteroid for topical application

Spray nasal dosed with 50 mcg / dose.

cytokine
Liophilizate for the preparation of a solution for subcutaneous administration, 50 μg, 80 μg, 100 μg, 120 μg (+ solvent: water for injection).
glucocorticosteroid for topical use + antibiotic-aminoglycoside + antifungal agent
Cream for external use, 0.05% + 0.1% + 1%.
Antitumor agent, antiandrogen.
Tablets of 250 mg.
antibiotic-aminoglycoside + glucocorticosteroid

Ointment for external use, 0,1% + 0,1%.

glucocorticosteroid for topical application
Ointment for external use, 0.1%.
glucocorticosteroid for topical application
Cream for external use, 0,1%.
Glucocorticosteroid for topical application
Ointment for external use 0,1%.
Glucocorticosteroid for topical application

Cream for external use 0,1%.

antiallergic agent - H1-histamine receptor blocker
Tablets for resorption, 2.5 mg and 5 mg.
antiallergic agent - H1-histamine receptor blocker

Syrup, 0.5 mg / ml.

antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 5 mg.